RichardSHotchkissMD
Anesthesiology • Saint Louis, MOCritical Care Medicine
Professor, Anesthesiology, Washington University in St. Louis School of Medicine
Are you Dr. Hotchkiss?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 74 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1 Barnes Jewish Hospital Plz
Dept Anesthesiology
Saint Louis, MO 63110Phone+1 800-862-9980Fax+1 314-362-1185
Summary
- Dr. Richard Hotchkiss, MD is a board certified anesthesiologist in Saint Louis, Missouri. He is currently licensed to practice medicine in Missouri and Georgia. He is a Professor at Washington University in St. Louis School of Medicine.
Education & Training
Massachusetts General HospitalResidency, Anesthesiology, 1981 - 1984
Emory University School of MedicineResidency, Internal Medicine, 1976 - 1980
University of Virginia School of MedicineClass of 1976- Massachusetts General HospitalFellowship, Critical Care Medicine (Anesthesiology)
Certifications & Licensure
MO State Medical License 1987 - 2025
GA State Medical License 1977 - 1987- American Board of Anesthesiology Anesthesiology
- American Board of Anesthesiology Critical Care Medicine
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Emergency Department (ED) Flow-directed Fluid Optimization Resuscitation Trial (EFFORT) Start of enrollment: 2010 Jul 01
- A Study of IL-7 to Restore Absolute Lymphocyte Counts in Sepsis Patients Start of enrollment: 2016 Jan 01
- Recombinant Interleukin-7 (CYT107) to Restore Absolute Lymphocyte Counts in Sepsis Patients Start of enrollment: 2019 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 123 citationsImmune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumabRichard S. Hotchkiss, Elizabeth Colston, Sachin Yende, Elliott D. Crouser, Greg S. Martin
Intensive Care Medicine. 2019-10-01 - 1066 citationsImmunosuppression in patients who die of sepsis and multiple organ failure.Jonathan S. Boomer, Kathleen To, Kathy Chang, Osamu Takasu, Dale F. Osborne
JAMA. 2011-12-21 - 241 citationsDelayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsisPavan Brahmamdam, Shigeaki Inoue, Jacqueline Unsinger, Katherine Chang, Jonathan E. McDunn
Journal of Leukocyte Biology. 2010-08-01
Press Mentions
Immunity Boosting Treatment Enhances CAR-T Cell Therapy for Blood CancersJune 13th, 2022- Bacterial Sepsis Increases Hippocampal Fibrillar Amyloid Plaque Load and Neuroinflammation in a Mouse Model of Alzheimer's DiseaseFebruary 5th, 2021
- Fight Against COVID-19 Aided by Sepsis ResearchersJanuary 13th, 2021
- Join now to see all
Grant Support
- Prevention Of Apoptotic Cell Death In Sepsis By BCL-2National Institute Of General Medical Sciences2003–2011
- Cellular Mechanisms Of Sepsis And Organ FailureNational Institute Of General Medical Sciences1997–2011
- Postdoctoral Training Program In Critical CareNational Institute Of General Medical Sciences2009–2010
- Cellular Injury And AdaptationNational Institute Of General Medical Sciences2008
- Prevention Of Apoptotic Cell Death In Sepsis By BCL-2National Institute Of General Medical Sciences1999–2002
- Calcium Homeostasis During Sepsis Examined By 19F NMRNational Institute Of General Medical Sciences1992–1998
